Introduction Vasodilatory shock, often treated with catecholamines, presents significant risks such as tachydysrhythmias and organ injury. Angiotensin II, a synthetic vasopressor, has shown promise in increasing mean arterial pressure while reducing vasopressor requirements (1). This study explores the effect of pre-admission use of angiotensin-con